SCHEMBL5822933

SCHEMBL5822933

COc1ccc(-c2nc(N3CCCCC3)sc2-c2n[c]ncc2C2CCCCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 4/20 0.48
NPSR1 Q6W5P4 3/20 0.48
HTT P42858 2/20 0.48
HRH3 Q9Y5N1 3/20 0.40
CETP P11597 1/20 0.39
SMN1; SMN2 Q16637 5/20 0.38
MAPT P10636 3/20 0.38
KDM4E B2RXH2 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HPGD P15428 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PTGS2 P35354 1/20 0.38
MEN1 O00255 1/20 0.37
PKM P14618 1/20 0.37
TP53 P04637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5822733 1.00 KMT2A (0.51) KMT2AALDH1A1NPSR1HTTHRH3
SCHEMBL5813372 0.97 KMT2A (0.52) KMT2AALDH1A1NPSR1HTTHRH3
SCHEMBL5815362 0.94 KMT2A (0.61) KMT2AALDH1A1NPSR1HTTHRH3
SCHEMBL5812232 0.93 KMT2A (0.62) KMT2AALDH1A1NPSR1HTTHRH3
SCHEMBL5817700 0.92 KMT2A (0.48) KMT2AALDH1A1NPSR1HTTHRH3
SCHEMBL5818863 0.89 KMT2A (0.51) KMT2AALDH1A1NPSR1HTTHRH3
SCHEMBL5817154 0.88 KMT2A (0.50) KMT2AALDH1A1NPSR1HTTCETP
SCHEMBL5818619 0.87 KCNH2 (0.39) KMT2AALDH1A1NPSR1HTTHRH3
SCHEMBL5818644 0.87 KCNH2 (0.39) KMT2AALDH1A1NPSR1HTTHRH3
SCHEMBL5818533 0.84 KCNH2 (0.40) KMT2AALDH1A1NPSR1HTTHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed